We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Cytokinetics
CYTK
$9.72B
| $796K | ﹤0.01% |
33,751
+31,527
| +1,418% | +$591K |
|
1327
Strategic Education
STRA
$1.79B
| $796K | ﹤0.01% |
+5,179
| New | +$808K |
|
1328
CenterPoint Energy
CNP
$25.4B
| $792K | ﹤0.01% |
42,404
-500
| -1% | -$8.61K |
|
1329
Bank of Hawaii
BOH
$2.94B
| $788K | ﹤0.01% |
12,824
-573
| -4% | -$35.4K |
|
1330
J.M. Smucker
SJM
$13.2B
| $787K | ﹤0.01% |
7,437
-48
| -0.6% | -$5.39K |
|
1331
MSC Industrial Direct
MSM
$6.8B
| $786K | ﹤0.01% |
10,790
-1,970
| -15% | -$127K |
|
|
FL
1332
DELISTED
Foot Locker
FL
| $782K | ﹤0.01% |
26,821
-2,355
| -8% | -$62.2K |
|
1333
Skyworks Solutions
SWKS
$13.7B
| $781K | ﹤0.01% |
6,113
-139,326
| -96% | -$15.4M |
|
1334
FNB Corp
FNB
$6.42B
| $780K | ﹤0.01% |
104,012
+15,480
| +17% | +$117K |
|
|
REVG
1335
DELISTED
REV Group
REVG
| $779K | ﹤0.01% |
+127,691
| New | +$685K |
|
|
THS
1336
DELISTED
Treehouse Foods
THS
| $779K | ﹤0.01% |
17,780
-781
| -4% | -$38.1K |
|
|
TXNM
1337
TXNM Energy Inc
TXNM
$6.04B
| $777K | ﹤0.01% |
20,220
+554
| +3% | +$22.1K |
|
|
SNV
1338
DELISTED
Synovus
SNV
| $776K | ﹤0.01% |
37,796
+9,716
| +35% | +$188K |
|
1339
Integra LifeSciences
IART
$1.17B
| $772K | ﹤0.01% |
16,435
-2,732
| -14% | -$134K |
|
1340
PDS Biotechnology
PDSB
$61M
| $772K | ﹤0.01% |
384,000
| – | – |
|
1341
Marriott International
MAR
$87.1B
| $771K | ﹤0.01% |
8,996
+5,903
| +191% | +$513K |
|
1342
Plug Power
PLUG
$2.96B
| $771K | ﹤0.01% |
+93,941
| New | +$440K |
|
1343
Pinnacle Financial Partners Inc
PNFP
$14.6B
| $770K | ﹤0.01% |
18,340
+629
| +4% | +$25K |
|
1344
RLI Corp
RLI
$5.55B
| $765K | ﹤0.01% |
18,642
+1,616
| +9% | +$63.7K |
|
1345
Interactive Brokers
IBKR
$40B
| $764K | ﹤0.01% |
73,184
-4,072
| -5% | -$42.6K |
|
1346
Dow Inc
DOW
$21.3B
| $762K | ﹤0.01% |
18,696
-6,563
| -26% | -$240K |
|
1347
Carrier Global
CARR
$44.8B
| $761K | ﹤0.01% |
+34,212
| New | +$636K |
|
1348
KB Home
KBH
$2.98B
| $761K | ﹤0.01% |
24,810
-30,433
| -55% | -$837K |
|
|
MCHB
1349
Mechanics Bancorp
MCHB
$3.42B
| $759K | ﹤0.01% |
30,824
+30,552
| +11,232% | +$710K |
|
1350
RLJ Lodging Trust
RLJ
$1.66B
| $758K | ﹤0.01% |
80,311
-542,613
| -87% | -$5.07M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.